Pharma counterfeiting endangers public health and economy
Professor Bejon Kumar Misra, International Consumer Policy Expert, explains how even after becoming the 'pharmacy of the world,'…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Guest Blogs
Revised EU GMP Annex 1‐ Manufacture of sterile medicinal products
The main driver for the update was to reflect changes in regulatory and manufacturing environments which include a clear shift to…
Accelerating pharma innovation through technology
Dr Shraddha Bhure, Medical Director, Boehringer Ingelheim India, explains how a technology-driven R&D machinery is going to be…
Biocatalysis: An essential tool for API synthesis
Naveen Kulkarni, CEO, Quantumzyme, explains how the area of biocatalysis is progressing quickly and the advantages it brings for…
Decoding compliance management in pharma sector
Rishi Agrawal, Co-founder and CEO, TeamLease Regtech, explains the numerous challenges encountered by the pharma industry, while…
The dominance of trade in health
Reflecting that the recent accident in Gambia should be a wakeup call for Indian pharma companies, Dr Suresh Saravdekar, former…
Conservation of endangered medicinal species “Picrorhiza kurroa”
Dr Arvind Saklani,Vice President,Agri Biotech, Sami Sabsina Group, traces down the origin, history, benefits, farming aspects,…
Navigating Section 194R with respect to pharma business organisations and way forward
Dr Sandeep Narula, Director, Pharm Tech Management, Shobhaben Pratapbhai Patel School of Pharmacy and Technology Management…
India can continue to be number one in generic pharma business
Achal Saran Pande, Partner, Vector Consulting Group, explains how India's generic pharma business, despite facing challenges…
Emerging opportunities in EU generics market
Major investment rebates and subsidies will be available under the European Union’s Pharmaceutical Strategy for Europe which will…
Centre appoints high-level committee to examine pharma marketing of drugs
Sanjay Kumar, Partner, TMT Law Practice, looks into the various factors associated with UCPMP for pharma companies
Advanced antibodies will revolutionise the future of Immuno-Oncology (IO)
Hannah Hall, Consultant, Citeline, explains how the field of immuno-oncology is poised to transform with the help of advanced…
Raw material prices affect margins of pharma drugs
Raheel Shah, Director, BDR Pharma, explains why pharma sector requires extraordinary precision and attention at every stage…
Digital transformation and emerging opportunities
Digital transformation is advancing rapidly, and the focus today has shifted from adopting specific technologies to the broader…
FSP model in clinical research industry: A natural progression and synergistic approach for FSO…
Sameer Arora, Director- Lead, Functional Service Provider (FSP), SIRO Clinpharm, explains how the FSP model is helping in changing…
Challenges and strategies for rare diseases trials in India
Krutikesh Age, Co-founder, DPHS, sheds light on the challenges that Indian pharma companies and research organisations face while…
Drug repurposing
Dr Arun Kumar Pandey, Senior Vice President, Research and Development, Alkem Laboratories, explains the various advantages,…
Role of IP in pharma industry
T Srinivasan, Director, Lakshmikumaran & Sridharan Attorney, traces down the various reasons and explains why Pharma companies…
AI and automation in clinical trials
Manuj Vangipurapu, founder and CEO, Clinion, briefly discusses the many well-known and lesser-known uses of AI and automation in…
Role of Ayurveda in Indian healthcare
Pradeep Multani, President, PHD Chamber, traces down the role of Ayurveda in Indian healthcare and the need to further promote it